Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GaPs: Pertussis Vaccination in Pregnancy and Infants
NCT03606096Phase 4Unknown
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2019
- Primary completion
- May 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Boostrix Polio in pertussis (4 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Pertussis Toxin specific antibody Geometric Mean Concentration at 20 weeks. Status: unknown.
02
Drugs
Boostrix Polio
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT03606096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606096.